Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 146840, 16 pages
http://dx.doi.org/10.1155/2015/146840
Review Article

Milk Proteins, Peptides, and Oligosaccharides: Effects against the 21st Century Disorders

1Department of Human Development and Family Studies (Nutritional Science & Education), National Taiwan Normal University, No.162, Section 1, Heping East Road, Taipei 106, Taiwan
2Instituto de Investigación en Ciencias de la Alimentación (CIAL, CSIC-UAM, CEI UAM+CSIC), Nicolás Cabrera 9, 28049 Madrid, Spain
3Food Science Department, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA
4Foods for Health Institute, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA

Received 21 October 2014; Accepted 21 December 2014

Academic Editor: Jinsong Ren

Copyright © 2015 Chia-Chien Hsieh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Lamarche, “Review of the effect of dairy products on non-lipid risk factors for cardiovascular disease,” Journal of the American College of Nutrition, vol. 27, no. 6, pp. 741S–746S, 2008. View at Google Scholar · View at Scopus
  2. C. Jaffiol, “Milk and dairy products in the prevention and therapy of obesity, type 2 diabetes and metabolic syndrome,” Bulletin de l'Academie Nationale de Medecine, vol. 192, no. 4, pp. 749–758, 2008. View at Google Scholar · View at Scopus
  3. K. Uenishi, “Prevention of osteoporosis by foods and dietary supplements. Prevention of osteoporosis by milk and dairy products,” Clinical Calcium, vol. 16, no. 10, pp. 1606–1614, 2006. View at Google Scholar · View at Scopus
  4. Y. Shimazaki, T. Shirota, K. Uchida et al., “Intake of dairy products and periodontal disease: the Hisayama study,” Journal of Periodontology, vol. 79, no. 1, pp. 131–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. M. Weaver, “Should dairy be recommended as part of a healthy vegetarian diet? Point,” The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1634S–1637S, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Pufulete, “Intake of dairy products and risk of colorectal neoplasia,” Nutrition Research Reviews, vol. 21, no. 1, pp. 56–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Ginter, “Vegetarian diets, chronic diseases and longevity,” Bratislavské Lekárske Listy, vol. 109, no. 10, pp. 463–466, 2008. View at Google Scholar · View at Scopus
  8. R. Nagpal, P. V. Behare, M. Kumar et al., “Milk, milk products, and disease free health: an updated overview,” Critical Reviews in Food Science and Nutrition, vol. 52, no. 4, pp. 321–333, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Nagpal, P. Behare, R. Rana et al., “Bioactive peptides derived from milk proteins and their health beneficial potentials: an update,” Food and Function, vol. 2, no. 1, pp. 18–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. S. Newburg, “Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans,” Journal of Animal Science, vol. 87, no. 13, pp. 26–34, 2009. View at Google Scholar · View at Scopus
  11. G. V. Coppa, P. Pierani, L. Zampini, I. Carloni, A. Carlucci, and O. Gabrielli, “Oligosaccharides in human milk during different phases of lactation,” Acta Paediatrica, vol. 88, no. 430, pp. 89–94, 1999. View at Google Scholar · View at Scopus
  12. O. Ballard and A. L. Morrow, “Human milk composition: nutrients and bioactive factors,” Pediatric Clinics of North America, vol. 60, no. 1, pp. 49–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. S. Newburg and S. H. Neubauer, “Carbohydrates in milks: analysis, quantities, and significance,” in Handbook of Milk Composition, R. G. Jensen, Ed., chapter 4, pp. 273–349, Academic Press, San Diego, Calif, USA, 1995. View at Google Scholar
  14. M. B. Engfer, B. Stahl, B. Finke, G. Sawatzki, and H. Daniel, “Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract,” American Journal of Clinical Nutrition, vol. 71, no. 6, pp. 1589–1596, 2000. View at Google Scholar · View at Scopus
  15. G. V. Coppa, L. Zampini, T. Galeazzi et al., “Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris,” Pediatric Research, vol. 59, no. 3, pp. 377–382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. E. Carlson and S. G. House, “Oral and intraperitoneal administration of N-acetylneuraminic acid: effect on rat cerebral and cerebellar N-acetylneuraminic acid,” Journal of Nutrition, vol. 116, no. 5, pp. 881–886, 1986. View at Google Scholar · View at Scopus
  17. N. Klein, A. Schwertmann, M. Peters, C. Kunz, and S. Strobe, “Immunomodulatory effects of breast milk oligosaccharides,” in Short and Long Term Effects of Breast Feeding on Child Health, B. Koletzko, K. F. Michaelsen, and O. Hernell, Eds., pp. 251–259, Springer, New York, NY, USA, 2002. View at Publisher · View at Google Scholar
  18. D. Divajeva, T. Marsh, S. Logstrup et al., “Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe,” BMC Public Health, vol. 14, no. 1, article 456, 2014. View at Publisher · View at Google Scholar
  19. W. Y. Huang, S. T. Davidge, and J. Wu, “Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment,” Critical Reviews in Food Science and Nutrition, vol. 53, no. 6, pp. 615–630, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. G. Chrysant and G. S. Chrysant, “An update on the cardiovascular pleiotropic effects of milk and milk products,” The Journal of Clinical Hypertension, vol. 15, no. 7, pp. 503–510, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. Engberink, M. A. H. Hendriksen, E. G. Schouten et al., “Inverse association between dairy intake and hypertension: the rotterdam study,” The American Journal of Clinical Nutrition, vol. 89, no. 6, pp. 1877–1883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. J. van Mierlo, L. R. Arends, M. T. Streppel et al., “Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials,” Journal of Human Hypertension, vol. 20, no. 8, pp. 571–580, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. Fitzgerald, B. A. Murray, and D. J. Walsh, “Hypotensive peptides from milk proteins,” Journal of Nutrition, vol. 134, no. 4, 2004. View at Google Scholar · View at Scopus
  24. D. Martínez-Maqueda, B. Miralles, I. Recio, and B. Hernández-Ledesma, “Antihypertensive peptides from food proteins: a review,” Food & Function, vol. 3, no. 4, pp. 350–361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Hernández-Ledesma, M. J. García-Nebot, S. Fernández-Tomé, L. Amigo, and I. Recio, “Dairy protein hydrolysates: peptides for health benefits,” International Dairy Journal, vol. 38, no. 2, pp. 82–100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. D. M. Contreras, R. Carrón, M. J. Montero, M. Ramos, and I. Recio, “Novel casein-derived peptides with antihypertensive activity,” International Dairy Journal, vol. 19, no. 10, pp. 566–573, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Recio, M. M. Contreras, B. Gómez-Sala, C. Vázquez, H. Fernández-Escribano, and R. del Campo, “Effect of a casein hydrolysate containing novel peptides in hypertensive subjects,” Annals of Nutrition and Metabolism, vol. 58, no. 3, pp. 16–17, 2011. View at Google Scholar
  28. P. Ruiz-Giménez, M. C. Burguete, M. Castelló-Ruiz et al., “Bovine lactoferrin pepsin hydrolysate exerts inhibitory effect on angiotensin I-converting enzyme-dependent vasoconstriction,” International Dairy Journal, vol. 17, no. 10, pp. 1212–1215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Ruiz-Giménez, J. B. Salom, J. F. Marcos et al., “Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides,” Food Chemistry, vol. 131, no. 1, pp. 266–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Fernández-Musoles, P. Manzanares, M. C. Burguete, E. Alborch, and J. B. Salom, “In vivo angiotensin I-converting enzyme inhibition by long-term intake of antihypertensive lactoferrin hydrolysate in spontaneously hypertensive rats,” Food Research International, vol. 54, no. 1, pp. 627–632, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Sugai, U. Murakami, and Y. Yamori, “Angiotensin converting enzyme inhibitors,” Japanese Patent, 62270533, 1995.
  32. J. A. Cadée, C.-Y. Chang, C.-W. Chen, C.-N. Huang, S.-L. Chen, and C.-K. Wang, “Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects,” American Journal of Hypertension, vol. 20, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Abubakar, T. Saito, H. Kitazawa, Y. Kawai, and T. Itoh, “Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion,” Journal of Dairy Science, vol. 81, no. 12, pp. 3131–3138, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. G.-W. Chen, J.-S. Tsai, and B. Sun Pan, “Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation,” International Dairy Journal, vol. 17, no. 6, pp. 641–647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Hernández-Ledesma, M. Miguel, L. Amigo, M. A. Aleixandre, and I. Recio, “Effect of simulated gastrointestinal digestion on the antihypertensive properties of synthetic β-lactoglobulin peptide sequences,” Journal of Dairy Research, vol. 74, no. 3, pp. 336–339, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-S. Tsai, T.-J. Chen, B. S. Pan, S.-D. Gong, and M.-Y. Chung, “Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk,” Food Chemistry, vol. 106, no. 2, pp. 552–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Nakamura, N. Yamamoto, K. Sakai, A. Okubo, S. Yamazaki, and T. Takano, “Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk,” Journal of Dairy Science, vol. 78, no. 4, pp. 777–783, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Nakamura, N. Yamamoto, K. Sakai, and T. Takano, “Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme,” Journal of Dairy Science, vol. 78, no. 6, pp. 1253–1257, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. A. H. Pripp, “Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials,” Food and Nutrition Research, vol. 52, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-Y. Xu, L.-Q. Qin, P.-Y. Wang, W. Li, and C. Chang, “Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials,” Nutrition, vol. 24, no. 10, pp. 933–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L.-Q. Qin, J.-Y. Xu, J.-Y. Dong, Y. Zhao, P. van Bladeren, and W. Zhang, “Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, no. 5, pp. 395–402, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. F. Engberink, E. G. Schouten, F. J. Kok, L. A. J. van Mierlo, I. A. Brouwer, and J. M. Geleijnse, “Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial,” Hypertension, vol. 51, no. 2, pp. 399–405, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Usinger, L. T. Jensen, B. Flambard, A. Linneberg, and H. Ibsen, “The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension,” Journal of Human Hypertension, vol. 24, no. 10, pp. 678–683, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. F. G. Cicero, B. Gerocarni, L. Laghi, and C. Borghi, “Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials,” Journal of Human Hypertension, vol. 25, no. 7, pp. 425–436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. A. F. G. Cicero, F. Aubin, V. Azais-Braesco, and C. Borghi, “Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in european subjects? A meta-analysis of randomized controlled trials,” American Journal of Hypertension, vol. 26, no. 3, pp. 442–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), “Scientific opinion on the substantion of health claims related to isoleucineproline-proline (IPP) and valine-proline-proline (VPP) and maintenance of normal blood pressure (ID 615, 661, 1831, 1832, 2891), and maintenance of the elastic properties of the arteries (ID 1832) pursuant to Article 13(1) of regulation (EC) No 1924/2006 on request from the European Commission,” EFSA Journal, vol. 7, pp. 1259–1277, 2009. View at Google Scholar
  47. M. Miguel, I. Recio, M. Ramos, M. A. Delgado, and M. A. Aleixandre, “Antihypertensive effect of peptides obtained from Enterococcus faecalis-fermented milk in rats,” Journal of Dairy Science, vol. 89, no. 9, pp. 3352–3359, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. C. Rodríguez-Figueroa, A. F. González-Córdova, M. J. Torres-Llanez, H. S. Garcia, and B. Vallejo-Cordoba, “Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains,” Journal of Dairy Science, vol. 95, no. 10, pp. 5536–5543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. J. C. Rodríguez-Figueroa, A. F. González-Córdova, H. Astiazaran-García, and B. Vallejo-Cordoba, “Hypotensive and heart rate-lowering effects in rats receiving milk fermented by specific Lactococcus lactis strains,” British Journal of Nutrition, vol. 109, no. 5, pp. 827–833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Erdmann, B. W. Y. Cheung, and H. Schröder, “The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease,” The Journal of Nutritional Biochemistry, vol. 19, no. 10, pp. 643–654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Pihlanto, “Antioxidative peptides derived from milk proteins,” International Dairy Journal, vol. 16, no. 11, pp. 1306–1314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. O. Power, P. Jakeman, and R. J. Fitzgerald, “Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides,” Amino Acids, vol. 44, no. 3, pp. 797–820, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Zommara, H. Toubo, M. Sakono, and K. Imaizumi, “Prevention of peroxidative stress in rats fed on a low vitamin e-containing diet by supplementing with a fermented bovine milk whey preparation: effect of lactic acid and β-lactoglobulin on the antiperoxidative action,” Bioscience, Biotechnology and Biochemistry, vol. 62, no. 4, pp. 710–717, 1998. View at Publisher · View at Google Scholar · View at Scopus
  54. T. Kullisaar, E. Songisepp, M. Mikelsaar, K. Zilmer, T. Vihalemm, and M. Zilmer, “Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects,” British Journal of Nutrition, vol. 90, no. 2, pp. 449–456, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Tompa, A. Laine, A. Pihlanto, H. Korhonen, I. Rogelj, and P. Marnilab, “Chemiluminescence of non-differentiated THP-1 promonocytes: developing an assay for screening anti-inflammatory milk proteins and peptides,” The Journal of Biological and Chemical Luminiscence, vol. 26, no. 4, pp. 251–258, 2010. View at Google Scholar
  56. X.-Y. Mao, X. Cheng, X. Wang, and S.-J. Wu, “Free-radical-scavenging and anti-inflammatory effect of yak milk casein before and after enzymatic hydrolysis,” Food Chemistry, vol. 126, no. 2, pp. 484–490, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. K. D. Ballard, R. S. Bruno, R. L. Seip et al., “Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial,” Nutrition Journal, vol. 8, article 34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Nagaoka, Y. Kanamaru, and Y. Kuzuya, “Effects of whey protein and casein on the plasma and liver lipids in rats,” Agricultural and Biological Chemistry, vol. 55, no. 3, pp. 813–818, 1991. View at Publisher · View at Google Scholar
  59. S. Nagaoka, Y. Kanamaru, Y. Kuzuya, T. Kojima, and T. Kuwata, “Comparative studies on the serum cholesterol lowering action of the whey protein and soybean protein in rats,” Bioscience, Biotechnology and Biochemistry, vol. 56, no. 9, pp. 1484–1485, 1992. View at Publisher · View at Google Scholar
  60. S. Nagaoka, Y. Futamura, K. Miwa et al., “Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin,” Biochemical and Biophysical Research Communications, vol. 281, no. 1, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Yamauchi, K. Ohinata, and M. Yoshikawa, “β-Lactotensin and neurotensin rapidly reduce serum cholesterol via NT2 receptor,” Peptides, vol. 24, no. 12, pp. 1955–1961, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Shimizu, “Interaction between food substances and the intestinal epithelium,” Bioscience, Biotechnology and Biochemistry, vol. 74, no. 2, pp. 232–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Shimizu, “Functional food in Japan: current status and future of gut-modulating food,” Journal of Food and Drug Analysis, vol. 20, no. 1, pp. 213–216, 2012. View at Google Scholar · View at Scopus
  64. J. Claustre, F. Toumi, A. Trompette et al., “Effects of peptides derived from dietary proteins on mucus secretion in rat jejunum,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 283, no. 3, pp. G521–G528, 2002. View at Google Scholar · View at Scopus
  65. A. Trompette, J. Claustre, F. Caillon, G. Jourdan, J. A. Chayvialle, and P. Plaisancié, “Milk bioactive peptides and β-casomorphins induce mucus release in rat jejunum,” Journal of Nutrition, vol. 133, no. 11, pp. 3499–3503, 2003. View at Google Scholar · View at Scopus
  66. S. Zoghbi, A. Trompette, J. Claustre et al., “β-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a μ-opioid pathway,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1105–G1113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Plaisancié, J. Claustre, M. Estienne et al., “A novel bioactive peptide from yoghurts modulates expression of the gel-forming MUC2 mucin as well as population of goblet cells and Paneth cells along the small intestine,” Journal of Nutritional Biochemistry, vol. 24, no. 1, pp. 213–221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Martínez-Maqueda, B. Miralles, M. Ramos, and I. Recio, “Effect of β-lactoglobulin hydrolysate and β-lactorphin on intestinal mucin secretion and gene expression in human goblet cells,” Food Research International, vol. 54, no. 1, pp. 1287–1291, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. K. S. Han, A. Deglaire, R. Sengupta, and P. J. Moughan, “Hydrolyzed casein influences intestinal mucin gene expression in the rat,” Journal of Agricultural and Food Chemistry, vol. 56, no. 14, pp. 5572–5576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. R. C. Sprong, A. J. Schonewille, and R. van der Meer, “Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota,” Journal of Dairy Science, vol. 93, no. 4, pp. 1364–1371, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Faure, C. Mettraux, D. Moennoz et al., “Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats,” Journal of Nutrition, vol. 136, no. 6, pp. 1558–1564, 2006. View at Google Scholar · View at Scopus
  72. G. A. Castro, J. E. Carvalho, S. V. Tinti, A. Possenti, and V. C. Sgarbieri, “Anti-ulcerogenic effect of a whey protein isolate and collagen hydrolysates against ethanol ulcerative lesions on oral administration to rats,” Journal of Medicinal Food, vol. 13, no. 1, pp. 83–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. L. F. H. Mezzaroba, J. E. Carvalho, A. N. Ponezi et al., “Antiulcerative properties of bovine α-lactalbumin,” International Dairy Journal, vol. 16, no. 9, pp. 1005–1012, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. S. S. Comstock, E. A. Reznikov, N. Contractor, and S. M. Donovan, “Dietary bovine lactoferrin alters mucosal and systemic immune cell responses in neonatal piglets,” Journal of Nutrition, vol. 144, no. 4, pp. 525–532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. Z. Tang, Y. Yin, Y. Zhang et al., “Effects of dietary supplementation with an expressed fusion peptide bovine lactoferricin-lactoferrampin on performance, immune function and intestinal mucosal morphology in piglets weaned at age 21 d,” British Journal of Nutrition, vol. 101, no. 7, pp. 998–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. G. A. Biziulevičius, V. Žukaite, T. Normantiene, G. Biziulevičiene, and I. G. Arestov, “Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis,” FEMS Immunology and Medical Microbiology, vol. 39, no. 2, pp. 155–161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Otani, K. Nakano, and T. Kawahara, “Stimulatory effect of a dietary casein phosphopeptide preparation on the mucosal IgA response of mice to orally ingested lipopolysaccharide from Salmonella typhimurium,” Bioscience, Biotechnology and Biochemistry, vol. 67, no. 4, pp. 729–735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. G. Vinderola, C. Matar, and G. Perdigón, “Milk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity,” BMC Immunology, vol. 8, no. 19, pp. 19–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Kitamura and H. Otani, “Fecal IgA levels in healthy persons who ingested cakes with or without bovine casein phosphopeptides,” Milchwissenschaft, vol. 57, no. 11-12, pp. 611–614, 2002. View at Google Scholar · View at Scopus
  80. D. E. W. Chatterton, D. N. Nguyen, S. B. Bering, and P. T. Sangild, “Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 8, pp. 1730–1747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. F. S. De Medina, A. Daddaoua, P. Requena et al., “New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation,” Proceedings of the Nutrition Society, vol. 69, no. 3, pp. 454–462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. G. T. Sousa, F. S. Lira, J. C. Rosa et al., “Dietary whey protein lessens several risk factors for metabolic diseases: a review,” Lipids in Health and Disease, vol. 11, article 67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. A. S. Gad, Y. A. Khadrawy, A. A. El-Nekeety, S. R. Mohamed, N. S. Hassan, and M. A. Abdel-Wahhab, “Antioxidant activity and hepatoprotective effects of whey protein and Spirulina in rats,” Nutrition, vol. 27, no. 5, pp. 582–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. E. M. Hamad, S. H. Taha, A.-G. I. Abou Dawood, M. Z. Sitohy, and M. Abdel-Hamid, “Protective effect of whey proteins against nonalcoholic fatty liver in rats,” Lipids in Health and Disease, vol. 10, article 57, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Chitapanarux, P. Tienboon, S. Pojchamarnwiputh, and D. Leelarungrayub, “Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients,” Journal of Gastroenterology and Hepatology, vol. 24, no. 6, pp. 1045–1050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. J. E. de Aguilar-Nascimento, B. R. Prado Silveira, and D. B. Dock-Nascimento, “Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial,” Nutrition, vol. 27, no. 4, pp. 440–444, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. R. López-Posadas, P. Requena, R. González et al., “Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis,” Journal of Nutrition, vol. 140, no. 11, pp. 2014–2019, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Requena, A. Daddaoua, E. Martínez-Plata et al., “Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17,” British Journal of Pharmacology, vol. 154, no. 4, pp. 825–832, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. B. E. Turbay, A. de Moreno de LeBlanc, G. Perdigón, G. S. de Giori, and E. M. Hebert, “β-Casein hydrolysate generated by the cell envelope-associated proteinase of Lactobacillus delbrueckii ssp. lactis CRL 581 protects against trinitrobenzene sulfonic acid-induced colitis in mice,” Journal of Dairy Science, vol. 95, no. 3, pp. 1108–1118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. R. E. Pratley and A. Salsali, “Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes,” Current Medical Research and Opinion, vol. 23, no. 4, pp. 919–931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Reihner, “Type 2 diabetes in children and adolescents,” World Journal of Diabetes, vol. 4, no. 6, pp. 270–281, 2013. View at Google Scholar
  92. K. M. Hirahatake, J. L. Slavin, K. C. Maki, and S. H. Adams, “Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions,” Metabolism: Clinical and Experimental, vol. 63, no. 5, pp. 618–627, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. D. J. Drucker and M. A. Nauck, “The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes,” The Lancet, vol. 368, no. 9548, pp. 1696–1705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. P. V. Bharatam, D. S. Patel, L. Adane, A. Mittal, and S. Sundriyal, “Modeling and informatics and designing anti-diabetic agents,” Current Pharmaceutical Design, vol. 13, no. 34, pp. 3518–3530, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. M. A. Nauck, N. Kleine, C. Ørskov, J. J. Holst, B. Willms, and W. Creutzfeldt, “Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7–36 amide) in Type 2 (non-insulin-dependent) diabetic patients,” Diabetologia, vol. 36, no. 8, pp. 741–744, 1993. View at Publisher · View at Google Scholar · View at Scopus
  96. G. P. Fadini and A. Avogaro, “Cardiovascular effects of DPP-4 inhibition: beyond GLP-1,” Vascular Pharmacology, vol. 55, no. 1–3, pp. 10–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. P. T. Gunnarsson, M. S. Winzell, C. F. Deacon et al., “Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice,” Endocrinology, vol. 147, no. 7, pp. 3173–3180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. B. L. Petersen, L. S. Ward, E. D. Bastian, A. L. Jenkins, J. Campbell, and V. Vuksan, “A whey protein supplement decreases post-prandial glycemia,” Nutrition Journal, vol. 8, article 47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. G. T. D. Sousa, F. S. Lira, J. C. Rosa et al., “Dietary whey protein lessens several risk factors for metabolic diseases: a review,” Lipids in Health and Disease, vol. 11, article 67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. T. Akhavan, B. L. Luhovyy, P. H. Brown, C. E. Cho, and G. H. Anderson, “Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults,” American Journal of Clinical Nutrition, vol. 91, no. 4, pp. 966–975, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Gaudel, A. B. Nongonierma, S. Maher et al., “A whey protein hydrolysate promotes insulinotropic activity in a clonal pancreatic β-cell line and enhances glycemic function in ob/ob mice,” Journal of Nutrition, vol. 143, no. 7, pp. 1109–1114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. A. B. Nongonierma and R. J. Fitzgerald, “Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates,” Peptides, vol. 39, no. 1, pp. 157–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. S. T. Silveira, D. Martínez-Maqueda, I. Recio, and B. Hernández-Ledesma, “Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin,” Food Chemistry, vol. 141, no. 2, pp. 1072–1077, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Tulipano, V. Sibilia, A. M. Caroli, and D. Cocchi, “Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors,” Peptides, vol. 32, no. 4, pp. 835–838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Uchida, Y. Ohshiba, and O. Mogami, “Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin,” Journal of Pharmacological Sciences, vol. 117, no. 1, pp. 63–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. H. Uenishi, T. Kabuki, Y. Seto, A. Serizawa, and H. Nakajima, “Isolation and identification of casein-derived dipeptidyl-peptidase 4 (DPP-4)-inhibitory peptide LPQNIPPL from gouda-type cheese and its effect on plasma glucose in rats,” International Dairy Journal, vol. 22, no. 1, pp. 24–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. I. M. E. Lacroix and E. C. Y. Li-Chan, “Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach,” Journal of Functional Foods, vol. 4, no. 2, pp. 403–422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. A. B. Nongonierma, C. Mooney, D. C. Shields, and R. J. Fitzgerald, “In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors,” Peptides, vol. 57, pp. 43–51, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. F. Bray and B. Møller, “Predicting the future burden of cancer,” Nature Reviews Cancer, vol. 6, no. 1, pp. 63–74, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. M. M. Manson, “Cancer prevention—the potential for diet to modulate molecular signalling,” Trends in Molecular Medicine, vol. 9, no. 1, pp. 11–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. T. M. de Kok, S. G. van Breda, and M. M. Manson, “Mechanisms of combined action of different chemopreventive dietary compounds,” European Journal of Nutrition, vol. 47, no. 2, supplement, pp. 51–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. E. G. De Mejia and V. P. Dia, “The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells,” Cancer and Metastasis Reviews, vol. 29, no. 3, pp. 511–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. R. K. Kanwar and J. R. Kanwar, “Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer,” Protein & Peptide Letters, vol. 20, no. 4, pp. 450–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. S. J. Furlong, J. S. Mader, and D. W. Hoskin, “Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts,” Experimental and Molecular Pathology, vol. 88, no. 3, pp. 371–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. G. Pepe, G. C. Tenore, R. Mastrocinque, P. Stusio, and P. Campiglia, “Potential anticarcinogenic peptides from bovine milk,” Journal of Amino Acids, vol. 2013, Article ID 939804, 7 pages, 2013. View at Publisher · View at Google Scholar
  116. J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin, “Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells,” The American Journal of Pathology, vol. 169, no. 5, pp. 1753–1766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. C. Yoo, S. Watanabe, R. Watanabe, K. Hata, K. I. Shimazaki, and I. Azuma, “Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice,” Japanese Journal of Cancer Research, vol. 88, no. 2, pp. 184–190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  118. L. Tone Eliassen, G. Berge, B. Sveinbjørnsson, J. S. Svendsen, L. H. Vorland, and Ø. Rekdal, “Evidence for a direct antitumor mechanism of action of bovine lactoferricin,” Anticancer Research, vol. 22, no. 5, pp. 2703–2710, 2002. View at Google Scholar · View at Scopus
  119. L. T. Eliassen, G. Berge, A. Leknessund et al., “The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo,” International Journal of Cancer, vol. 119, no. 3, pp. 493–500, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. C. R. Brinkmann, S. Thiel, and D. E. Otzen, “Protein-fatty acid complexes: biochemistry, biophysics and function,” FEBS Journal, vol. 280, no. 8, pp. 1733–1749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. A.-K. Mossberg, Y. Hou, M. Svensson, B. Holmqvist, and C. Svanborg, “HAMLET treatment delays bladder cancer development,” The Journal of Urology, vol. 183, no. 4, pp. 1590–1597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Perego, S. Cosentino, A. Fiorilli, G. Tettamanti, and A. Ferraretto, “Casein phosphopeptides modulate proliferation and apoptosis in HT-29 cell line through their interaction with voltage-operated L-type calcium channels,” Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 808–816, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. S. Perego, A. Zabeo, E. Marasco et al., “Casein phosphopeptides modulate calcium uptake and apoptosis in Caco2 cells through their interaction with the TRPV6 calcium channel,” Journal of Functional Foods, vol. 5, no. 2, pp. 847–857, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Hatzoglou, E. Bakogeorgou, C. Hatzoglou, P.-M. Martin, and E. Castanas, “Antiproliferative and receptor binding properties of α- and β-casomorphins in the T47D human breast cancer cell line,” European Journal of Pharmacology, vol. 310, no. 2-3, pp. 217–223, 1996. View at Publisher · View at Google Scholar · View at Scopus
  125. R. Maneckjee, R. Biswas, and B. K. Vonderhaar, “Binding of opioids to human MCF-7 breast cancer cells and their effects on growth,” Cancer Research, vol. 50, no. 8, pp. 2234–2238, 1990. View at Google Scholar · View at Scopus
  126. V. Packard, Human Milk and Infant Formula, Elsevier/Academic Press, New York, NY, USA, 2012.
  127. A. M. Zivkovic and D. Barile, “Bovine milk as a source of functional oligosaccharides for improving human health,” Advances in Nutrition, vol. 2, no. 3, pp. 284–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. D. Barile and R. A. Rastall, “Human milk and related oligosaccharides as prebiotics,” Current Opinion in Biotechnology, vol. 24, no. 2, pp. 214–219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Lange, D. C. Dallas, A. le Parc, J. M. L. N. de Moura Bell, and D. Barile, “Human nutrition: determining functional properties ans sources of recently identified food components: oligosaccharides, glycolipids, glycoproteins and peptides,” in Encyclopedia of Agriculture and Food Systems, N. van Alfen, Ed., 461, p. 441, Elsevier, New York, NY, USA, 2014. View at Google Scholar
  130. G. Boehm and G. Moro, “Structural and functional aspects of prebiotics used in infant nutrition,” Journal of Nutrition, vol. 138, no. 9, pp. 1818S–1828S, 2008. View at Google Scholar · View at Scopus
  131. G. R. Gibson and M. B. Roberfroid, “Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics,” Journal of Nutrition, vol. 125, no. 6, pp. 1401–1412, 1995. View at Google Scholar · View at Scopus
  132. T. Urashima, E. Taufik, K. Fukuda, and S. Asakuma, “Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals,” Bioscience, Biotechnology and Biochemistry, vol. 77, no. 3, pp. 455–466, 2013. View at Publisher · View at Google Scholar · View at Scopus
  133. D. Barile, M. Marotta, C. Chu et al., “Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry,” Journal of Dairy Science, vol. 93, no. 9, pp. 3940–3949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. K. Mariño, J. A. Lane, J. L. Abrahams et al., “Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophilic interaction chromatography,” Glycobiology, vol. 21, no. 10, pp. 1317–1330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. R. W. Veh, J.-C. Michalski, A. P. Corfield, M. Sander-Wewer, D. Gies, and R. Schauer, “New chromatographic system for the rapid analysis and preparation of colostrum sialyloligosaccharides,” Journal of Chromatography A, vol. 212, no. 3, pp. 313–322, 1981. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Meyrand, D. C. Dallas, H. Caillat, F. Bouvier, P. Martin, and D. Barile, “Comparison of milk oligosaccharides between goats with and without the genetic ability to synthesize αs1-casein,” Small Ruminant Research, vol. 113, no. 2-3, pp. 411–420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. A. Martinez-Ferez, S. Rudloff, A. Guadix et al., “Goats' milk as a natural source of lactose-derived oligosaccharides: isolation by membrane technology,” International Dairy Journal, vol. 16, no. 2, pp. 173–181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  138. D. Barile, N. Tao, C. B. Lebrilla, J.-D. Coisson, M. Arlorio, and J. B. German, “Permeate from cheese whey ultrafiltration is a source of milk oligosaccharides,” International Dairy Journal, vol. 19, no. 9, pp. 524–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Roberfroid, “Prebiotics: the concept revisited,” The Journal of Nutrition, vol. 137, supplement 2, no. 3, pp. 830S–837S, 2007. View at Google Scholar · View at Scopus
  140. Z.-T. Yu, C. Chen, and D. S. Newburg, “Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes,” Glycobiology, vol. 23, no. 11, pp. 1281–1292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. G. A. Weiss, C. Chassard, and T. Hennet, “Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice,” British Journal of Nutrition, vol. 111, no. 9, pp. 1602–1610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  142. D. L. Oliveira, A. Costabile, R. A. Wilbey, A. S. Grandison, L. C. Duarte, and L. B. Roseiro, “In vitro evaluation of the fermentation properties and potential prebiotic activity of caprine cheese whey oligosaccharides in batch culture systems,” BioFactors, vol. 38, no. 6, pp. 440–449, 2012. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Nagler-Anderson, “Man the barrier! Strategic defences in the intestinal mucosa,” Nature Reviews Immunology, vol. 1, no. 1, pp. 59–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  144. D. S. Newburg and W. A. Walker, “Protection of the neonate by the innate immune system of developing gut and of human milk,” Pediatric Research, vol. 61, no. 1, pp. 2–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. H. H. Tong, M. A. McIver, L. M. Fisher, and T. F. DeMaria, “Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium,” Microbial Pathogenesis, vol. 26, no. 2, pp. 111–119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  146. A. L. Morrow, G. M. Ruiz-Palacios, M. Altaye et al., “Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants,” Journal of Pediatrics, vol. 145, no. 3, pp. 297–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  147. P. M. Simon, P. L. Goode, A. Mobasseri, and D. Zopf, “Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides,” Infection and Immunity, vol. 65, no. 2, pp. 750–757, 1997. View at Google Scholar · View at Scopus
  148. A. Imberty, Y. M. Chabre, and R. Roy, “Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins,” Chemistry, vol. 14, no. 25, pp. 7490–7499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. M. X. Maldonado-Gómez, H. Lee, D. Barile, M. Lu, and R. W. Hutkins, “Adherence inhibition of enteric pathogens to epithelial cells by bovine colostrum fractions,” International Dairy Journal, vol. 40, pp. 24–32, 2015. View at Publisher · View at Google Scholar
  150. J. Hakkarainen, M. Toivanen, A. Leinonen et al., “Human and bovine milk oligossaccharides inhibit Neisseria meningitidis pili attachment in vitro,” Journal of Nutrition, vol. 135, no. 10, pp. 2445–2448, 2005. View at Google Scholar · View at Scopus
  151. D. S. Newburg, G. M. Ruiz-Palacios, and A. L. Morrow, “Human milk glycans protect infants against enteric pathogens,” Annual Review of Nutrition, vol. 25, no. 1, pp. 37–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  152. C. F. Manthey, C. A. Autran, L. Eckmann, and L. Bode, “Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and EPEC colonization in suckling mice,” Journal of Pediatric Gastroenterology and Nutrition, vol. 58, no. 2, pp. 165–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. A. Daddaoua, V. Puerta, P. Requena et al., “Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis,” Journal of Nutrition, vol. 136, no. 3, pp. 672–676, 2006. View at Google Scholar · View at Scopus
  154. F. Lara-Villoslada, E. Debras, A. Nieto et al., “Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis,” Clinical Nutrition, vol. 25, no. 3, pp. 477–488, 2006. View at Publisher · View at Google Scholar · View at Scopus
  155. C. Ashley, W. H. Johnston, C. L. Harris, S. I. Stolz, J. L. Wampler, and C. L. Berseth, “Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial,” Nutrition Journal, vol. 11, no. 1, article 38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Fanaro, B. Marten, R. Bagna et al., “Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study,” Journal of Pediatric Gastroenterology and Nutrition, vol. 48, no. 1, pp. 82–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  157. M. E. Davis, A. Rao, S. Gauthier, Y. Pouliot, L. Gourley, and A. Allain, “Preparing an aqueous solution of whey protein isolate and a proteolytic enzyme, holding solution under conditions effective to partially hydrolyze whey protein isolate to provide a hydrolysate having increased ACE-suppressing activity in mammals,” US Patent, 6998259, 2006.
  158. I. Recio, I. López-Expósito, A. Quirós et al., “Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same,” WO Patent, 131586, 2006.
  159. O. Tossavainen, T. Suomalainen, J. Sahlstein, and A. M. Makinen, “Process for producing a product containing antihypertensive tripeptides,” US Patent, 6972282 B1, 2005.
  160. E. Damiens, I. Yazidi, J. Mazurier, I. Duthile, G. Spik, and Y. Boilly-Marer, “Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells,” Journal of Cellular Biochemistry, vol. 74, no. 3, pp. 486–498, 1999. View at Publisher · View at Google Scholar
  161. X. Sun, R. Jiang, A. Przepiorski, S. Reddy, K. P. Palmano, and G. W. Krissansen, “‘Iron-saturated’ bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice,” BMC Cancer, vol. 12, article 591, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. B. Fang, M. Zhang, M. Tian, L. Jiang, H. Y. Guo, and F. Z. Ren, “Bovine lactoferrin binds oleic acid to form an anti-tumor complex similar to HAMLET,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1841, no. 4, pp. 535–543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  163. J. S. Mader, J. Salsman, D. M. Conrad, and D. W. Hoskin, “Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines,” Molecular Cancer Therapeutics, vol. 4, no. 4, pp. 612–624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. H. M. Habib, W. H. Ibrahim, R. Schneider-Stock, and H. M. Hassan, “Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities,” Food Chemistry, vol. 141, no. 1, pp. 148–152, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. J. R. Kanwar, G. Mahidhara, and R. K. Kanwar, “Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy,” Nanomedicine, vol. 7, no. 10, pp. 1521–1550, 2012. View at Publisher · View at Google Scholar · View at Scopus
  166. C. Freiburghaus, B. Janicke, H. Lindmark-Månsson, S. M. Oredsson, and M. A. Paulsson, “Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line,” Journal of Dairy Science, vol. 92, no. 6, pp. 2477–2484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. C. Freiburghaus, H. Lindmark-Månsson, M. Paulsson, and S. Oredsson, “Reduction of ultraviolet light-induced DNA damage in human colon cancer cells treated with a lactoferrin-derived peptide,” Journal of Dairy Science, vol. 95, no. 10, pp. 5552–5560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  168. N. Zemann, P. Klein, E. Wetzel, F. Huettinger, and M. Huettinger, “Lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in HeLa cells,” Biochimie, vol. 92, no. 7, pp. 880–884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. A. Varadhachary, J. S. Wolf, K. Petrak et al., “Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy,” International Journal of Cancer, vol. 111, no. 3, pp. 398–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. Y.-C. Yoo, R. Watanabe, Y. Koike et al., “Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species,” Biochemical and Biophysical Research Communications, vol. 237, no. 3, pp. 624–628, 1997. View at Publisher · View at Google Scholar · View at Scopus
  171. J. S. Mader, A. Richardson, J. Salsman et al., “Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria,” Experimental Cell Research, vol. 313, no. 12, pp. 2634–2650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  172. T.-N. Zhang and N. Liu, “Effect of bovine lactoferricin on DNA methyltransferase 1 levels in Jurkat T-leukemia cells,” Journal of Dairy Science, vol. 93, no. 9, pp. 3925–3930, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. G. Berge, L. T. Eliassen, K. A. Camilio, K. Bartnes, B. Sveinbjørnsson, and Ø. Rekdal, “Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide,” Cancer Immunology, Immunotherapy, vol. 59, no. 8, pp. 1285–1294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  174. Y. T. Tung, H. L. Chen, C. C. Yen et al., “Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor,” Journal of Dairy Science, vol. 96, no. 4, pp. 2095–2106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. M. Deng, W. Zhang, H. Tang et al., “Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms,” Oncogene, vol. 32, no. 36, pp. 4273–4283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  176. T. Sakai, Y. Banno, Y. Kato, Y. Nozawa, and M. Kawaguchi, “Pepsin-digested bovine lactoferrin induces apoptotic cell death with JNK/SAPK activation in oral cancer cells,” Journal of Pharmacological Sciences, vol. 98, no. 1, pp. 41–48, 2005. View at Publisher · View at Google Scholar · View at Scopus